CLOSE X

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE9407.0040 (+0.43 %)
PREV CLOSE ( ) 9367.00
OPEN PRICE ( ) 9427.40
BID PRICE (QTY) 9405.30 (50)
OFFER PRICE (QTY) 9409.30 (2)
VOLUME 5882
TODAY'S LOW / HIGH ( )9377.40 9450.00
52 WK LOW / HIGH ( )5637.5 10000
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-10 1990
Management Info
Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72 / 23 (P) / Divis / 303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 66966300 / 400

Email mail@divislabs.com

Website www.divislabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
01Aug Divis Laboratories informs about outco
Further to letter dated July 20, 2026, Divis Laboratories has informed t..
31Jul Divi's Laboratories informs about ces
Divi's Laboratories has informed that L. Ramesh Babu, Vice President (Pr..
24Jul Divi's Laboratories informs about ear
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
20Jul Divi's Laboratories informs about boa
Divi's Laboratories has informed that a meeting of Board of Directors of..
13Jul Divis Laboratories informs about AGM
Divis Laboratories has informed that it enclosed copies of notice to the..
Financials
Rs. in Millions
QTR Jun 26 ANNUAL 26
Net Profit891026070
Gross Profit 11650 34360
Operating Profit 1303039940
Net Sales 29740103880
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Kwality Pharma (BSE)
 3788.70 (9.01%)
M.Cap ( in Cr)3906.28
Torrent Pharma (BSE)
 4957.20 (3.18%)
M.Cap ( in Cr)188757.55
Mankind Pharma (BSE)
 2427.80 (4.74%)
M.Cap ( in Cr)100204.74
Wockhardt (BSE)
 2182.50 (4.58%)
M.Cap ( in Cr)35472.04
Glenmark Pharma. (BSE)
 2465.90 (3.61%)
M.Cap ( in Cr)69645.99
Shareholding Pattern
PROMOTERS 51.88%
MUTUAL FUNDS/UTI 13.87%
NON-INSTITUTION 8.54%
FI/BANKS/INSURANCE 4.49%
GOVERNMENT 0%
FII 0%
Advisory for Investors Complaints Data August 2026 Broking Complaints Data August 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002
  • 6)Verified UPI ID for receiving Payments: badjate.rzp1.brk@validhdfc
  • 7)Click here for QR Code

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.